Holmes Ian, Berman Nathaniel, Domingues Vinicius
New York Presbyterian Hospital/Weill Cornell Medical College, New York, NY 10065, USA.
Case Rep Nephrol. 2014;2014:845372. doi: 10.1155/2014/845372. Epub 2014 Mar 5.
Phenazopyridine is a commonly used urinary analgesic available throughout the United States. Ingestion of large quantities can lead to methemoglobinemia, hemolytic anemia, jaundice, and acute renal failure. We report a case of a 78-year-old male with previously normal renal function who developed acute renal failure and jaundice without methemoglobinemia or hyperbilirubinemia after taking nearly 8 g of phenazopyridine over the course of 4 days. Initially presenting with oliguria, the urine output began to increase by day 2 of his admission, and the creatinine peaked 11 days after he began taking phenazopyridine, and he was discharged safely soon after. To our knowledge, this is the first such case of renal failure and jaundice without methemoglobinemia or hemolytic anemia in an adult patient with normal renal function.
非那吡啶是一种在美国广泛使用的尿路镇痛药。大量摄入可导致高铁血红蛋白血症、溶血性贫血、黄疸和急性肾衰竭。我们报告一例78岁男性病例,其肾功能此前正常,在4天内服用了近8克非那吡啶后出现急性肾衰竭和黄疸,但无高铁血红蛋白血症或高胆红素血症。最初表现为少尿,入院第2天尿量开始增加,肌酐在开始服用非那吡啶11天后达到峰值,此后不久他安全出院。据我们所知,这是首例肾功能正常的成年患者出现肾衰竭和黄疸但无高铁血红蛋白血症或溶血性贫血的病例。